Phthalates (PAEs) are ubiquitous endocrine-disrupting chemicals (EDCs), but their association with early pregnancy loss (gestational age ≤ 12 weeks) remains controversial. This study enrolled pregnant women aged 20–45 years in Zunyi City, China, and included 107 cases and 349 controls following propensity score matching. Logistic regression, restricted cubic spline (RCS) analysis, Bayesian kernel machine regression (BKMR), and weighted quantile sum (WQS) regression were employed to investigate associations between urinary phthalate metabolites and early pregnancy loss. We found that monoethyl phthalate (MEP), mono(2-ethylhexyl) phthalate (MEHP), monooctyl phthalate (MOP), mono(2-ethyl-5-oxohexyl) phthalate (MEOHP), and mono(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP) were associated with spontaneous abortion in early pregnancy, with corresponding odds ratios (ORs; 95% confidence intervals CIs) of 1.62 (1.26–2.09), 1.49 (1.07–2.09), 1.64 (1.26–2.12), 1.78 (1.27–2.50), 2.63 (1.90–3.64), 1.41 (1.11–1.79), and 5.39 (3.53–8.25). Non-linear dose–response relationships were observed between exposure to MMP, MEP, MEHP, MOP, monobenzyl phthalate (MBZP), MEOHP, MEHHP, and mono-(3-carboxypropyl) phthalate (MECPP) and early pregnancy loss (non-linear p < 0.05; overall p < 0.05). Co-exposure to multiple phthalate metabolites was also linked to a significantly non-linear elevation in the risk of early pregnancy loss (OR; 95% confidence interval CI) of 1.92 (1.76–2.15). Among these metabolites, MMP, MOP, MEOHP, and MECPP make the largest contribution to the correlation. In summary, our findings indicate that exposure to phthalate esters during early pregnancy is associated with early pregnancy loss, with MMP, MOP, MEOHP, and MECPP as the primary contributors. However, these results are based on a single urine sample, and caution is warranted when interpreting the findings.
Tao et al. (Mon,) studied this question.